Advertisement

Some Properties of Bovine High Molecular Weight Kininogen

  • M. Komiya
  • H. Kato
  • M. Yano
  • T. Suzuki
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 21)

Abstract

The presence of two kininogens has been shown in human, dog, guinea pig, rabbit and rat plasma by Jacobsen (1–3), in horse plasma by Henriques et al.(4), and in bovine plasma by Yano et al. (5). Pierce and Webster (6) isolated two low molecular weight (LMW) human kininogens with the same molecular weight of about 50,000 but with their kinin sequences carboxyl-terminal in one case and internal in the other. After that, two kininogens of different molecular weight were isolated from human plasma by Jacobsen and Kritz (7). LMW bovine kininogen (kininogen-II) has been highly purified by the groups of Habermann (8) and of Suzuki (9), and it was found by us that the kinin segment, which was thought to lie in the central part of LMW kininogen molecule, was released by trypsin, snake venom kininogenase or hog pancreatic kallikrein but not by glass-or casein-activated bovine plasma kallikrein. High molecular weight (HMW) kininogen (kininogen-I), a sensitive substrate of bovine plasma kallikrein, was isolated from bovine plasma by Yano et al.(10), and it was found that there is a methionyl-lysyl-bradykinin sequence located both at the carboxyl terminus and inside of the polypeptide chain of bovine HMW kininogen (11).

Keywords

High Molecular Weight Cyanogen Bromide Disc Electrophoresis Linear Gradient Elution Bovine Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    S. Jacobsen, Nature, 210, 98 (1966).PubMedCrossRefGoogle Scholar
  2. (2).
    S. Jacobsen, Brit. J. Pharmacol., 26, 403 (1966).PubMedGoogle Scholar
  3. (3).
    S. Jacobsen, Brit. J. Pharmacol., 28, 64 (1966).PubMedGoogle Scholar
  4. (4).
    B. Henriques, N. Kauritcheva, V. Kuznetsove and M. Astrakan, Nature, 215, 1200 (1967).PubMedCrossRefGoogle Scholar
  5. (5).
    M. Yano, S. Nagasawa, K. Horiuchi and T. Suzuki, J. Biochem., 62, 504 (1967).PubMedGoogle Scholar
  6. (6).
    J.V. Pierce and M.E. Webster, “Hypotensive Peptide”, ed. by E.G. Erdös et al., Springer-Verlag (N.Y.), p.130 (1966).Google Scholar
  7. (7).
    S. Jacobsen and M. Kritz, Brit. J. Pharmacol., 29, 25 (1967).PubMedGoogle Scholar
  8. (8).
    E. Habermann, W. Klett and G. Rosenbusch, Z. Physiol. Chem., 332, 121 (1963).CrossRefGoogle Scholar
  9. (9).
    T. Suzuki, Y. Mizushima, T. Sato and S. Iwanaga, J. Biochem., 57, 14 (1965).Google Scholar
  10. (10).
    M. Yano, S. Nagasawa and T. Suzuki, J. Biochem., 69, 471 (1971).PubMedGoogle Scholar
  11. (11).
    M. Yano, S. Nagasawa and T. Suzuki, Biochem. Biophys. Res. Communs., 40, 914 (1970).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • M. Komiya
    • 1
  • H. Kato
    • 1
  • M. Yano
    • 1
  • T. Suzuki
    • 1
  1. 1.Institute for Protein ResearchOsaka UniversityOsakaJapan

Personalised recommendations